← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2010Last known activity
Nov 1, 2024
Timeline
1970s
- Jan 1, 1971
Griffith University— Founded
Drugs by trial phase (41 distinct, 15 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Bacterial Infections
- Carcinoma, Ovarian Epithelial
- Communicable Diseases
- Gonorrhea
- Gram-Positive Bacterial Infections
- Hemolysis
- Hemorrhage
- Infections
- Lung Diseases
- Motor Neuron Disease
- Mycobacterium Infections
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pharyngitis
- Pneumonia
- Sclerosis
- Streptococcal Infections
- Virus Diseases
Recent trials (21)
- NCT06409364OfficialPhase 2Nov 1, 2024
- NCT06622551OfficialN/AAug 1, 2024
- NCT06622551Lead sponsorN/AAug 1, 2024
- NCT06622551Sponsor investigatorN/AAug 1, 2024
- NCT05591677CollaboratorPhase 2Dec 31, 2022
- NCT04882514Overall official - principal investigatorPhase 1/Phase 2Jan 31, 2022
- NCT04882514CollaboratorPhase 1/Phase 2Jan 31, 2022
- NCT04997954Lead sponsorPhase 4Oct 31, 2021
- NCT04415424CollaboratorPhase 3Oct 31, 2020
- NCT04496245CollaboratorPhase 3Aug 24, 2020
- NCT04310930CollaboratorPhase 2/Phase 3Mar 31, 2020
- NCT04089150Study chairPhase 2Sep 30, 2019
- NCT03690791Lead sponsorPhase 3Oct 31, 2018
- NCT03361163CollaboratorPhase 1Jun 27, 2018
- NCT03508141Lead sponsorPhase 2Jun 1, 2018
Details
- Founded
- Nathan, AU Jan 1, 1971
- Last known activity
- Nov 1, 2024